国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2012年
11期
1565-1566
,共2页
邓元将%李芬%李志爱%李俊达%吴小龙
鄧元將%李芬%李誌愛%李俊達%吳小龍
산원장%리분%리지애%리준체%오소룡
热敏灸%奥美拉唑%胃食管反流病
熱敏灸%奧美拉唑%胃食管反流病
열민구%오미랍서%위식관반류병
Thermal moxibustion%Omeprazole%Gastroesophageal reflux disease
目的 探讨热敏灸联合奥美拉唑治疗胃食管反流病的临床效果.方法 选取2010年2月至2011年12月在我院门诊就诊的胃食管反流病患者共200例,将其随机分成治疗组100例和对照组100例;治疗组采用穴位热敏灸联合奥美拉唑治疗,对照组单独服用奥美拉唑肠溶片.观察两组患者的临床疗效及不良反应.结果 治疗组总有效率为92.00%,而对照组总有效率为73.00%,两组总有效率比较差异具有统计学意义(P< 0.05);治疗组患者无1例出现不良反应,而对照组患者出现5例恶心(5.00%)、3例腹泻(3.00%)和8例眩晕(8.00%).结论 热敏灸联合奥美拉唑治疗胃食管反流病,其临床疗效好,不良反应少,值得在临床上推广应用.
目的 探討熱敏灸聯閤奧美拉唑治療胃食管反流病的臨床效果.方法 選取2010年2月至2011年12月在我院門診就診的胃食管反流病患者共200例,將其隨機分成治療組100例和對照組100例;治療組採用穴位熱敏灸聯閤奧美拉唑治療,對照組單獨服用奧美拉唑腸溶片.觀察兩組患者的臨床療效及不良反應.結果 治療組總有效率為92.00%,而對照組總有效率為73.00%,兩組總有效率比較差異具有統計學意義(P< 0.05);治療組患者無1例齣現不良反應,而對照組患者齣現5例噁心(5.00%)、3例腹瀉(3.00%)和8例眩暈(8.00%).結論 熱敏灸聯閤奧美拉唑治療胃食管反流病,其臨床療效好,不良反應少,值得在臨床上推廣應用.
목적 탐토열민구연합오미랍서치료위식관반류병적림상효과.방법 선취2010년2월지2011년12월재아원문진취진적위식관반류병환자공200례,장기수궤분성치료조100례화대조조100례;치료조채용혈위열민구연합오미랍서치료,대조조단독복용오미랍서장용편.관찰량조환자적림상료효급불량반응.결과 치료조총유효솔위92.00%,이대조조총유효솔위73.00%,량조총유효솔비교차이구유통계학의의(P< 0.05);치료조환자무1례출현불량반응,이대조조환자출현5례악심(5.00%)、3례복사(3.00%)화8례현훈(8.00%).결론 열민구연합오미랍서치료위식관반류병,기림상료효호,불량반응소,치득재림상상추엄응용.
Objecifive To explore the clinical efficacy of thermal moxibustion combined with omeprazole for gastroesophageal reflux disease ( GERD ).Methods 200 patients with GERD who visited our clinic from February 2010 to December 2011 were randomly divided into study group and control group.The study group received combination therapy with thermal moxibustiou and omeprazole while the control group received omeprazole alone.The clinical efficacy and adverse reactions were observed in the two groups.Results There was significant difference between the two groups in the total effectiveness rate ( 92.00% vs.73.00%,P< 0.05 ).No adverse reactions were found in the study group; whereas sicchasia occurred in 5 patients ( 5.00% ) diarrhea in 3 ( 3.00% ),and dizziness in 8 ( 8.00% ) in the control gorup.Conclusions Combination therapy with thermal moxibustion and omeprazole for gastroesophageal reflux disease is effective and has fewer adverse reactions.It is worth popularizing clinically.